Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-Induced G2 Delay and Mitotic Defects
出版年份 2013 全文链接
标题
Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-Induced G2 Delay and Mitotic Defects
作者
关键词
-
出版物
Scientific Reports
Volume 3, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-09-12
DOI
10.1038/srep02640
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of p21 by HDAC Inhibitors Requires Acetylation of H2A.Z
- (2013) Luca Bellucci et al. PLoS One
- Regulation of a Novel Androgen Receptor Target Gene, the Cyclin B1 Gene, through Androgen-Dependent E2F Family Member Switching
- (2012) Y. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
- (2011) M. J. LaBonte et al. CANCER RESEARCH
- Cyclin B1 is rate limiting but not essential for mitotic entry and progression in mammalian somatic cells
- (2011) Deena V. Soni et al. CELL CYCLE
- Suppression of Polo like kinase 1 (PLK1) by p21Waf1 mediates the p53-dependent prevention of caspase-independent mitotic death
- (2011) Yi-Cheng Lin et al. CELLULAR SIGNALLING
- Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
- (2011) Maria Graziella Catalano et al. INTERNATIONAL JOURNAL OF CANCER
- Radioprotection by the histone deacetylase inhibitor phenylbutyrate
- (2011) Alexandra C. Miller et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
- (2010) Dana Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells
- (2010) Piergiorgio Pettazzoni et al. FREE RADICAL BIOLOGY AND MEDICINE
- Antitumor activities and on-target toxicities mediated by a TRAIL receptor agonist following cotreatment with panobinostat
- (2010) Ben P. Martin et al. INTERNATIONAL JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo
- (2010) Eric Sanchez et al. LEUKEMIA RESEARCH
- Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells
- (2010) William Brazelle et al. PLoS One
- Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma
- (2009) Michael Dickinson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis
- (2009) Y.-L. Chung et al. CARCINOGENESIS
- In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
- (2009) E. M. Ocio et al. HAEMATOLOGICA
- The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
- (2009) Michael B Prystowsky et al. JOURNAL OF PATHOLOGY
- The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair
- (2009) P Maiso et al. LEUKEMIA
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
- (2008) A. Scuto et al. BLOOD
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
- (2008) Mark Petronczki et al. DEVELOPMENTAL CELL
- Transcriptional regulation of human polo-like kinases and early mitotic inhibitor
- (2008) Moe Tategu et al. Journal of Genetics and Genomics
- Histone Deacetylase Inhibitors Protect against and Mitigate the Lethality of Total-Body Irradiation in Mice
- (2008) Stephen L. Brown et al. RADIATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now